| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | F Paul Buckley | |
| Amarpreet Chawla | |||
| Benjamin Havemann | |||
| P2860 | cites work | Gastroesophageal reflux disease: A review of surgical decision making | Q26769066 |
| Management of the patient with incomplete response to PPI therapy | Q27025882 | ||
| The role of endoscopy in the management of GERD | Q28260295 | ||
| Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease. | Q33462032 | ||
| Efficacy of Magnetic Sphincter Augmentation versus Nissen Fundoplication for Gastroesophageal Reflux Disease in Short Term: A Meta-Analysis. | Q33561533 | ||
| GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting | Q33583576 | ||
| Treatment of gastroesophageal reflux disease: use of algorithms to aid in management | Q33775716 | ||
| Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications | Q33890429 | ||
| Diagnosis and treatment of gastroesophageal reflux disease | Q34047646 | ||
| Acid infusion into the esophagus increases the number of meal-induced transient lower esophageal sphincter relaxations (TLESRs) in healthy volunteers. | Q34254419 | ||
| Guidelines for the diagnosis and management of gastroesophageal reflux disease | Q34328379 | ||
| GERD assessment including pH metry predicts a high response rate to PPI standard therapy | Q34549954 | ||
| The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus | Q34570296 | ||
| Referral of patients to specialists: factors affecting choice of specialist by primary care physicians | Q34628528 | ||
| American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease | Q34826775 | ||
| Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease | Q35118901 | ||
| Dropping the baton: specialty referrals in the United States | Q35178147 | ||
| Clinical significance of hiatal hernia | Q35195425 | ||
| Development of quality measures for the care of patients with gastroesophageal reflux disease | Q36169725 | ||
| LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis | Q36226312 | ||
| Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux | Q46289572 | ||
| Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. | Q47670014 | ||
| Introduction of mechanical sphincter augmentation for gastroesophageal reflux disease into practice: early clinical outcomes and keys to successful adoption | Q48085717 | ||
| Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey | Q48629907 | ||
| Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges | Q49829605 | ||
| Gastroesophageal reflux disease: A clinical overview for primary care physicians | Q49886092 | ||
| Manometric Changes to the Lower Esophageal Sphincter After Magnetic Sphincter Augmentation in Patients With Chronic Gastroesophageal Reflux Disease. | Q51228509 | ||
| Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. | Q51891570 | ||
| Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation: One Year Results From a Post Approval Study. | Q52561759 | ||
| Pathophysiology of Gastroesophageal Reflux Disease. | Q52679469 | ||
| Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis. | Q52689821 | ||
| Management of Gastroesophageal Reflux Disease. | Q53550915 | ||
| Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement. | Q53666202 | ||
| Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions | Q67930855 | ||
| The crural diaphragm, an external lower esophageal sphincter: a definitive study | Q72566317 | ||
| Selection criteria among gastroenterologists and surgeons for laparoscopic antireflux surgery | Q77965896 | ||
| Clinical effectiveness of laparoscopic fundoplication in a U.S. community | Q78834480 | ||
| High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD | Q79825451 | ||
| A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11) | Q84404040 | ||
| Correlation between pathological distal esophageal acid exposure and ineffective esophageal motility | Q85200902 | ||
| Studies on the regulation of transient lower esophageal sphincter relaxations (TLESRs) by acid in the esophagus and stomach | Q87113651 | ||
| Alternative therapies for GERD: a way to personalized antireflux surgery | Q88723920 | ||
| Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial | Q90380000 | ||
| LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux | Q36886513 | ||
| Quality of life following laparoscopic Nissen fundoplication: assessing short-term and long-term outcomes. | Q36975063 | ||
| Liquid in the gastroesophageal segment promotes reflux, but compliance does not: a mathematical modeling study | Q36977066 | ||
| Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients | Q37067053 | ||
| Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain | Q37330315 | ||
| Pulmonary manifestations of gastroesophageal reflux disease | Q37566266 | ||
| The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases | Q37644595 | ||
| Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications | Q37718284 | ||
| Guidelines for surgical treatment of gastroesophageal reflux disease | Q37781292 | ||
| Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease | Q37871345 | ||
| Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group | Q38033674 | ||
| Gastroesophageal reflux disease treatment: side effects and complications of fundoplication | Q38069859 | ||
| Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel | Q38131204 | ||
| Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study | Q38424408 | ||
| Physiology and pathogenesis of gastroesophageal reflux disease | Q38474903 | ||
| Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. | Q38520220 | ||
| Regurgitation in patients with gastroesophageal reflux disease | Q38618005 | ||
| An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease | Q38656704 | ||
| Recent advances in diagnostic testing for gastroesophageal reflux disease | Q38743090 | ||
| The Esophageal Sphincter Device for Treatment of GERD. | Q38832925 | ||
| Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. | Q38916823 | ||
| A Review of New Surgical and Endoscopic Therapies for Gastroesophageal Reflux Disease | Q38917902 | ||
| The Quality of Care for Gastroesophageal Reflux Disease | Q39060076 | ||
| A Modern Magnetic Implant for Gastroesophageal Reflux Disease | Q39063510 | ||
| Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. | Q39181093 | ||
| An electronic medical record-based intervention to improve quality of care for gastro-esophageal reflux disease (GERD) and atypical presentations of GERD | Q39950390 | ||
| Presentation and Epidemiology of Gastroesophageal Reflux Disease | Q40093651 | ||
| Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry | Q40272354 | ||
| Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. | Q40351345 | ||
| Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD. | Q40903234 | ||
| Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia? | Q41267128 | ||
| Diagnosis and management of esophageal chest pain. | Q42599371 | ||
| Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole | Q43619417 | ||
| Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients | Q43730793 | ||
| Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis | Q43939369 | ||
| The LINX® reflux management system: confirmed safety and efficacy now at 4 years | Q44116959 | ||
| Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment | Q45004669 | ||
| One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center | Q45210215 | ||
| The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. | Q45945270 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 472-476 | |
| P577 | publication date | 2019-08-01 | |
| P1433 | published in | World journal of gastrointestinal endoscopy | Q27723331 |
| P1476 | title | Magnetic sphincter augmentation: Optimal patient selection and referral care pathways | |
| P478 | volume | 11 |
Search more.